Palmer Square Capital BDC (NYSE:PSBD - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Palmer Square Capital BDC to post earnings of $0.47 per share and revenue of $34.90 million for the quarter. Parties that wish to listen to the company's conference call can do so using this link.
Palmer Square Capital BDC Stock Performance
Shares of NYSE PSBD traded down $0.31 during midday trading on Friday, hitting $15.30. 23,274 shares of the stock traded hands, compared to its average volume of 17,814. The company has a market cap of $499.38 million and a PE ratio of 7.97. Palmer Square Capital BDC has a one year low of $15.12 and a one year high of $17.12. The business has a 50 day moving average price of $15.65 and a two-hundred day moving average price of $15.94.
Palmer Square Capital BDC Company Profile
(
Get Free Report)
Palmer Square Capital BDC Inc is an externally managed, non-diversified closed-end management investment company which primarily lends to and invests in corporate debt securities, including small to large private U.S. companies and has elected to be regulated as a business development company. Palmer Square Capital BDC Inc is based in MISSION WOODS, Kan.
Featured Stories
Before you consider Palmer Square Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Palmer Square Capital BDC wasn't on the list.
While Palmer Square Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
